Inhalational anesthetic agents are chemical substances that are administered into the body via lungs and distributed to organs and tissues by blood circulation.
INTRODUCTION
Inhalational anesthetic agents are chemical substances administered into the body via lungs and distributed to organs and tissues by blood circulation. e main site of their action is the brain, but they also a ect other parts of central nervous system. In the brain, they act on the membranes of neurons. ey can facilitate inhibitory functions or attenuate excitation of neurons, which can result in general anesthesia. e characteristics of an ideal anesthetic agent should include: rapid induction and emergence, simple use, su cient analgesia, inhibition of re exes and relaxation of striated muscles, safety and absence of toxic adverse e ects. Volatile anesthetics used today have come close to the above described criteria, but do not ful ll them completely just yet. For these reasons, we combine them with other medications (intravenous anesthetics, opioids, nitrogenous oxide, muscle relaxants). Most o en, we use them in so called "balanced anesthesia".
is way, safety is increased, while negative adverse e ects are decreased. Recently, TCI (target-controlled anesthesia) with intravenous anesthetics is being used more and more. It would appear that intravenous anesthetics are going to completely push out the volatile anesthetics that had been used a lot in the past. But is this really going to happen?
IS THE NONSPECIFIC MECHANISM OF ACTION THE MAIN ADVANTAGE OF VOLATILE ANESTHETICS?
Intravenous anesthetics in use today, such as propofol and etomidate, work mainly by acting on GABA receptors. Relatively high selectivity of these compounds is apparent, when replacing one amino acid in the GABA receptor.
at can already counter the e ects of an intravenous anesthetic. Because of this high selectivity, intravenous anesthetics have generally less adverse e ects in comparison to volatile anesthetics. ere is also a possibility for development of selective antagonists, such as umazenil for benzodiazepines. High selectivity is not necessarily an advantage, though. For example, a minor mutation in a patient could decrease ecacy of intravenous anesthetic. Such mutations had already been proven. Expression of GABA receptor itself, for example in alcohol consumption or neurologic disorder, could also change the sensitivity for an intravenous anesthetic. In volatile anesthetics we do not encounter such phenomena. Even though they act on GABA receptors as well, they produce anesthesia by acting on di erent sites. If it turns out, that when propofol is not e cient in a patient, volatile anesthetics present an excellent alternative and can produce su cient depth of anesthesia (1) .
ere is also a di erence between volatile and intravenous anesthetics in their e ect on nociceptive and other neural pathways in the spinal cord. Intravenous anesthetics ensure good anesthesia and amnesia, but they do not a ect other structures in the spinal cord. Increased intake of propofol does not result in increased muscle relaxation, as opposed to volatile anesthetics.
at results in more frequent muscle contractions and movements with propofol. Intravenous anesthetics possibly inhibit spinal neurons that express GABA. is could increase excitability of spinal neural networks. Studies have shown that volatile anesthetics attenuate motor response to pain stimulus via glycine receptors. Glycine is, in fact, one of the main actors in spinal pain processing. Volatile anesthetics are the only substances that have a modulatory e ect on glycine receptors in clinically relevant doses (1) . It is also very desirable for a modern anesthetic to work by attenuating pain in the spinal cord aside from its anesthetic and anamnestic properties. at could decrease the chance of hyper-sensibilization and chronic pain development (1) . ese characteristics could make volatile anesthetics model compounds for development of new intravenous anesthetics. Modern intravenous anesthetics should, aside from their action on GABA receptors, in uence the glycine receptors as well. Such anesthetic agents are already being developed in laboratories. Development of intravenous agents that would work less speci cally and on multiple di erent receptors contradicts the principle that anesthetic substances should have a speci c mechanism of action (2). In the past, highly selective substances had been synthetized, but have resulted in unexpected consequences (3, 4) . A possible reason for that in biologic organisms could lie in their need for stability, result-SIGNA VITAE 2019; 15 2 : 14 17 ing in development of multiple copies of signaling pathways or production of compensatory mechanisms to counter the external disturbance. A more recent view in development of the new medications is not concentrated on highly selective drugs that would work on a speci c receptor anymore but rather on developing substances that trigger the molecular mechanism and work on interactions of signaling pathways-i.e. network pharmacology (4, 5) .
IMMUNOMODULATORY ACTION OF VOLATILE ANESTHETICS
Another reason for usage of volatile anesthetics is their bene cial immunomodulatory and anti-in ammatory e ect. Many studies have shown that volatile anesthetics reduce systemic and local in ammatory response during major surgery (6, 7) . Cellular-protective e ects of volatile anesthetics had rst been proven in cardiovascular surgery. Volatile anesthetics have proven cardio-protective e ect and have been applied for pre-and post-conditioning in open cardiac surgery with extracorporeal circulation (8) . Later, evidence of volatile anesthetics' bene cial e ects had emerged in other surgical elds as well. In UMC Ljubljana, Jerin et al. showed decreased perioperative inammation, when using volatile anesthetics in patients undergoing liver surgery (9) . Perioperative in ammatory response is dependent mainly on the type of anesthetic substance used. Lahat and McBridge showed in their studies, increased levels of cytokines in the blood immediately following induction, before the beginning of surgical procedure (10, 11) . Studies on cell cultures implied, that intravenous anesthetics encourage in ammatory cells to produce cytokines (12) . Intravenous anesthetics inhibit polarization of neutrophils and chemotaxis to a greater extent than their volatile counterparts. (13) Anesthetics do not only change non-speci c, but also speci c immune response by a ecting proliferation, lymphocyte count and levels of immunoglobulins in blood (14) . Limited animal data have suggested that volatile anesthetics can induce neuro-inammation, which leads to the decline of cognitive function in rodents. is e ect is yet to be veri ed in humans (15) . However, volatile anesthetics have been shown to accelerate post-ischemic neurogenesis, suggesting that they may also enhance endogenous reparative processes in the injured brain (16) .
ANESTHETICS AND INFLAMMATORY RESPONSE
In general, anesthetic agents cause an increase in production and levels of leukocytes in blood (17) . Every anesthetic a ects a di erent type of immune cells (Table 1 ) (17) . Anesthetic agents also a ect perioperative immune response with their e ect on synthesis and excretion of cytokines and glucocorticoids ( Table 2 ) (17) . General anesthetics and in ammation Propofol reduces production of pro-inammatory cytokines, alters expression of nitric oxide, and inhibits neutrophil function (18) . Researchers have been studying pro-in ammatory e ects of propofol for a long time, but so far, no published study has yet con rmed it. In ammation could be a result of apolipoprotein A-1 modulation. Ricou was the latest to start a study that would explore this, but there have been no published results yet (19) (20) (21) . Aside from anesthesia, volatile anesthetics have other e ects. Of those, inhibition of in ammatory response is especially important and bene cial (22) . at was rst shown by in vitro studies on animals (23) . Subsequent clinical studies have con rmed that, at rst in the eld of cardiac surgery. It was proven that sevo urane, when used in extracorporeal circulation, decreases expression of antigen receptor in granulocytes and polymorphonuclear (PMN) cells. Following studies showed decreased blood levels of pro-in ammatory cytokines (especially TNF-α, IL-6 and IL-8) a er using extracorporeal circulation (24) . A study from this eld was undertaken in Slovenia as well and it con rmed the benecial e ect of volatile anesthetics in cardiac surgery (25) . Anti-in ammatory characteristics of volatile anesthetics had also become a point of interest in the eld of thoracic surgery, where postoperative pulmonary in ammation is the main reason of perioperative morbidity and mortality. Studies have shown bene cial e ects of volatile anesthetics in sense of postoperative in ammation decrease and decrease of postopera- Table 1 . General anesthetics and their e ect on immune cells. On the other hand, study on patients undergoing craniotomy showed that propofol based anesthesia was associated with signi cantly higher anti-in ammatory cytokine IL-10 levels than anesthesia with sevo urane. ese ndings, however, seem to have little e ect on outcome, since neither sevo urane nor propofol had any signi cant impact on the occurrence of postoperative complications (27) . erefore, in general, it is possible to assert that inhalational and intravenous anesthetic agents, obviously with some minor exceptions, might play an important role in terms of neuroprotection during surgical procedures. Nevertheless, data seem to be insu cient to recommend any speci c an-esthetic agent as the optimal neuroprotective agent (28) .
Immune cell E ect

CONCLUSION
At present, available experimental data do not support the selection of any one anesthetic agent over the others. Modern intravenous anesthetic agents are substances that get very close to a theoretical ideal anesthetic, but volatile anesthetics still hold a place in modern anesthesia practice. Aside from anesthesia and amnesia they also have analgesic properties and muscle relaxant e ect. eir bene cial immunomodulatory e ect and anti-in ammatory e ect is desirable especially in major surgical pro-cedures, linked to substantial systemic inammatory response in the perioperative period. Lastly, both anesthetic techniques can be combined (intravenous and inhalational anesthesia). at increases the desirable e ects of both agents, while decreasing their adverse e ects.
